S&P 500 7,673.52 −0.58%
Nasdaq 26,421.41 −0.32%
S&P/TSX 36,123.05 −1.07%
Apple 316.22 −1.17%
Nvidia 225.73 −2.01%
Microsoft 493.95 −1.15%
Shopify 185.03 −7.84%
Royal Bank 288.21 −1.12%
CAD/USD 0.7260 +0.22%
CLOSED · 00:45 ET
Market ClerkRecap
Wed Sep 9 · markets closed1 signal on Sep 8198 insider buys this week · $380.2MCIRO short report next: Sep 14The week ahead

EMBC

Embecta Corp.
NASDAQ · HEALTH CARE · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
5.55
−0.25 −4.31%
USD · close Sep 8

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $314.5MP/E 3.8DIV YIELD 8.29%FCF YIELD 52.34%REV TTM $1B −7.6%NET INCOME $87.5M +4.7%NET DEBT $1.2B52W 2.90 – 15.31SEC XBRL · TTM TO Invalid Date

Financials

SEC XBRL · 29 PERIODS · WHOLE USD

By quarter

PeriodRevenueYoYGross marginOperating incomeNet incomeYoYEPSOp. cash flowCapexFree cash flowFiled
Q3 2026 · Jun 30$271.7M−8.1%56.4%$48.7M$21.1M−53.6%0.36$41.8M$1.1M$40.7MAug 7
Q2 2026 · Mar 31$221.8M−14.4%57.6%$35M−$4.1M−117.4%-0.07$31.1M$500K$30.6MMay 5
Q1 2026 · Dec 31$261.2M−0.3%61.9%$83.3M$44.1M0.74$17.2M$600K$16.6MFeb 5
Q4 2025 · Sep 30derived$264M−7.7%60.0%$56.5M$26.4M+80.8%0.44$84M$7.3M$76.7MNov 25
Q3 2025 · Jun 30$295.5M+8.4%66.7%$94M$45.5M+209.5%0.78$81.2M$400K$80.8MAug 7
Q2 2025 · Mar 31$259M−9.8%63.4%$62.9M$23.5M−18.7%0.40$31.8M$100K$31.7MMay 5
Q1 2025 · Dec 31$261.9M−5.6%60.0%$28.7M$0−100.0%0.00−$5.3M$1.5M−$6.8MFeb 5
Q4 2024 · Sep 30derived$286.1M+1.5%60.7%$26.2M$14.6M+143.3%0.24$26.6M$0$26.6MNov 25
Q3 2024 · Jun 30$272.5M69.8%$55.9M$14.7M0.25−$2.1M$9.7M−$11.8MAug 8
Q2 2024 · Mar 31$287.2M64.6%$39.2M$28.9M0.50$24.3M$3.4M$20.9MMay 9
Q1 2024 · Dec 31$277.3M67.0%$45.5M$20.1M0.35−$13.1M$2.7M−$15.8MFeb 6
Q4 2023 · Sep 30derived$281.9M64.5%$25.8M$6M0.10$29.6M$9.2M$20.4MNov 25

By fiscal year

YearRevenueGross marginOperating incomeNet incomeNet marginEPSOp. cash flowCapexFree cash flowBuybacksDividends paid
FY2025 · to Sep 30$1.1B62.6%$242.1M$95.4M8.8%1.62$191.7M$9.3M$182.4M$35M
FY2024 · to Sep 30$1.1B65.5%$166.8M$78.3M7.0%1.34$35.7M$15.8M$19.9M$34.5M
FY2023 · to Sep 30$1.1B66.9%$221.5M$70.4M6.3%1.22$67.7M$26.5M$41.2M$34.4M
FY2022 · to Sep 30$1.1B68.6%$309.6M$223.6M19.8%3.89$412.2M$23.6M$388.6M$8.6M
FY2021 · to Sep 30$1.2B68.7%$492M$414.8M35.6%7.28$456.3M$36.8M$419.5M$0
FY2020 · to Sep 30$1.1B70.3%$486.5M$427.6M39.4%7.50$498.5M$41.9M$456.6M$0

Every number comes from Embecta Corp.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.

Watch EMBC. Know when insiders buy.
One email the day a filing lands. Free.